CI

CI

USD

The Cigna Group Common Stock

$264.660+6.960 (2.701%)

Цена в режиме реального времени

Healthcare
Healthcare Plans
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$257.700

Максимум

$264.800

Минимум

$256.000

Объем

3.20M

Фундаментальные показатели компании

Рыночная капитализация

70.7B

Отрасль

Healthcare Plans

Страна

United States

Статистические данные торговли

Средний объем

1.74M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $239.51Текущая $264.660Максимум $350

Отчет об анализе ИИ

Последнее обновление: 3 нояб. 2025 г.
Сгенерировано ИИИсточник данных: Yahoo Finance, Bloomberg, SEC

Cigna (CI) Stock Analysis: Finding Opportunity in Recent Turmoil

What Happened to Cigna's Stock?

Cigna took a serious hit recently. On October 30th, shares plunged 18% to $247.10 on massive volume - nearly 5.5 times their average trading activity. The selling continued the next day, dropping the stock to $244.41. This puts CI dangerously close to its 52-week low of $240.67.

What's puzzling is this crash happened despite generally positive news. The company beat Q3 earnings estimates, Goldman Sachs just initiated coverage with a strong Buy rating and $370 price target (that's 50% above current levels), and they announced meaningful initiatives to reduce medication costs for Americans.

Reading Between the Price Lines

Let's unpack what's really happening with Cigna's chart:

  • The Setup: Through most of August and September, CI built a solid upward trend, climbing from $260 to over $310
  • The Breakdown: After peaking near $315, the stock drifted lower through October
  • The Crash: That October 30th drop was no ordinary correction - it was a full-blown panic sell-off

Here's what stands out: the volume spike on October 30th wasn't normal distribution. When volume jumps that high during a sharp decline, it usually means big institutional players are exiting positions all at once. The good news? The selling pressure appears exhausted - the follow-through day on October 31st showed much weaker volume.

Why This Might Be Your Entry Window

Three compelling reasons suggest the worst may be over:

  1. Technical Signals Flashing Green: The stock now sits right at its support level ($244.33). When prices bounce off support with conviction, it often marks a turning point. Right now, the distance between current price and support is practically nonexistent - meaning we're at the make-or-break point.

  2. Goldman's Confidence: Their $370 price target isn't some random number. At current levels, that represents serious upside potential. What's interesting is they're not alone - 24 analysts maintain strong buy ratings.

  3. The News/Price Disconnect: Positive earnings, strategic initiatives, and dividend stability shouldn't result in an 18% single-day drop. This mismatch creates what traders call "mispricing" - a temporary gap between actual value and market price

Связанные новости

Analyst Upgrades

Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market

Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting analyst target cuts.

Просмотреть больше
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Analyst Upgrades

TD Cowen Maintains Buy on Cigna Group, Lowers Price Target to $333

TD Cowen analyst Charles Rhyee maintains Cigna Group with a Buy and lowers the price target from $387 to $333.

Просмотреть больше
TD Cowen Maintains Buy on Cigna Group, Lowers Price Target to $333
Analyst Upgrades

Goldman Sachs Maintains Buy on Cigna Group, Lowers Price Target to $330

Goldman Sachs analyst Scott Fidel maintains Cigna Group with a Buy and lowers the price target from $370 to $330.

Просмотреть больше
Goldman Sachs Maintains Buy on Cigna Group, Lowers Price Target to $330
Analyst Upgrades

JP Morgan Maintains Overweight on Cigna Group, Lowers Price Target to $375

JP Morgan analyst Lisa Gill maintains Cigna Group with a Overweight and lowers the price target from $428 to $375.

Просмотреть больше
JP Morgan Maintains Overweight on Cigna Group, Lowers Price Target to $375
Analyst Upgrades

Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300

Barclays analyst Andrew Mok maintains Cigna Group with a Overweight and lowers the price target from $383 to $300.

Просмотреть больше
Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300
Reuters

Health insurer Cigna beats quarterly profit estimates on health services strength

Cigna Group beat Wall Street estimates for third-quarter profit on Thursday, driven by strength in the company's health services unit Evernorth that houses its pharmacy benefit management business.

PR Newswire

Evernorth Announces New Era of Pharmacy Benefit Services to Lower Americans' Medication Costs

Evernorth, the health services division of The Cigna Group (NYSE:CI) today announced a new rebate-free pharmacy benefit model designed to help...

Прогноз ИИBeta

Рекомендация ИИ

Бычий

Обновлено в: 5 нояб. 2025 г., 05:51

МедвежийНейтральныйБычий

68.6% Уверенность

Риск и торговля

Уровень риска1/5
Низкий риск
Подходит для
КонсервативныйСтоимость
Руководство по торговле

Точка входа

$244.87

Взять прибыль

$249.29

Остановить убытки

$219.96

Ключевые факторы

PDI 7.0 выше MDI 6.9 с ADX 11.9, что предполагает бычий тренд
Объем торгов в 12.7 раз превышает среднее значение (20,150), что указывает на чрезвычайно сильное покупательское давление
MACD 0.2199 выше сигнальной линии 0.2029, что указывает на бычье пересечение

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.